Plasma level of C3 in patients with PD (305.27 ± 205.16 μg/mL, Figure 1B) was significantly lower compared with NCs (444.34 ± 245.54 μg/mL, p = 0.002). This evidence concerns the gene C3 and Parkinson disease.